TAKEDA PHARMACEUTICAL CO LTD
TAKNYSE
$17.15
↑ +2.5%Jul 17 close · end-of-day
Price
1Y↑ +16.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in gastroenterology; oncology; neuroscience; and rare diseases. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig.
- CEO
- Christophe Weber
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 47,300
- Website
- takeda.com
Management & directors
- Bitetti Teresa MariePresident, OBU
- Duprey Lauren RusckowskiChief Transformation Officer
- Farajallah Awny Samaan BotrosChief Medical Officer
- Furney Natalie Anne MarieGlobal General Counsel
- Furuta MilanoChief Financial Officer
- Greenway Nicola Deidre PetalChief Human Resources Officer
- Ibrahim Ramy Riad AhmedPresident, PDT BU
- Kim Julie So-YoungPresident and CEO
- Miyabashira AsukaPresident, Japan Pharma B.U.
- Pacheco Rhonda JanicePresident, U.S. Business Unit
- Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev.
- Platford Giles RichardPresident, IBU
Roles derived from SEC Form 4 filings.
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Jul 16, 2026
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | GILLIS STEVEN | Award | 3,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | MARAGANORE JOHN | Award | 3,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Reed Kimberly A. | Award | 3,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Iijima Masami | Award | 1,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | BROUSSARD BRUCE D | Award | 3,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Stoffels Paulus | Award | 3,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Kimura Koichiro | Award | 1,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Tsusaka Miki | Award | 1,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Miyabashira Asuka· President, Japan Pharma B.U. | Award | 1,500 | $0.00 | $0.00 | filing |
| 2026-07-01 | Furuta Milano· Chief Financial Officer | Award | 12,300 | $0.00 | $0.00 | filing |
| 2026-07-01 | Platford Giles Richard· President, IBU | Award | 49,558 | $0.00 | $0.00 | filing |
| 2026-07-01 | Smoter Jennifer Marie· Chief Comm. & Gov. Officer | Award | 18,808 | $0.00 | $0.00 | filing |
| 2026-07-01 | Ibrahim Ramy Riad Ahmed· President, PDT BU | Award | 25,078 | $0.00 | $0.00 | filing |
| 2026-07-01 | Greenway Nicola Deidre Petal· Chief Human Resources Officer | Award | 22,570 | $0.00 | $0.00 | filing |
| 2026-07-01 | Farajallah Awny Samaan Botros· Chief Medical Officer | Award | 17,554 | $0.00 | $0.00 | filing |
| 2026-07-01 | Furney Natalie Anne Marie· Global General Counsel | Award | 43,886 | $0.00 | $0.00 | filing |
| 2026-07-01 | Pacheco Rhonda Janice· President, U.S. Business Unit | Award | 50,156 | $0.00 | $0.00 | filing |
| 2026-07-01 | Pignagnoli Agosti Marcello· Head, Strat. & Port. Dev. | Award | 27,586 | $0.00 | $0.00 | filing |
| 2026-07-01 | Ricci Gabriele· Chief Data & Tech. Officer | Award | 37,616 | $0.00 | $0.00 | filing |
| 2026-07-01 | Shannon Elaine Mary· Pres., Global Supply & Quality | Award | 30,094 | $0.00 | $0.00 | filing |
| 2026-07-01 | Duprey Lauren Rusckowski· Chief Transformation Officer | Award | 45,140 | $0.00 | $0.00 | filing |
| 2026-07-01 | Bitetti Teresa Marie· President, OBU | Award | 43,886 | $0.00 | $0.00 | filing |
| 2026-07-01 | Kim Julie So-Young· President and CEO | Award | 50,434 | $0.00 | $0.00 | filing |
| 2026-07-01 | Kim Julie So-Young· President and CEO | Award | 22,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Plump Andrew Stewart· President, R&D | Award | 125,390 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.